Skip to main content
Caplight Logo









Yaoyanshe

Yaoyanshe

Private
ShanghaiHealthcare & Life Scienceshttps://yaoyanshe.com/

Last Round

Series D

Aug 10, 2020

Total Funding Raised

$72.68M

Company Overview

Yaoyanshe is a healthtech company that provides an innovative digital clinical research organization (CRO) platform for pharmaceutical and medical device companies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Healthcare Analytics, Vertical SaaS, Project Management

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

contract research organizationCROsite management organizationSMOclinical trial managementclinical research softwareeClinicalpatient recruitmentclinical data managementregulatory complianceclinical research SaaSeTMFclinical trial platformpharma R&Ddigital CRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yaoyanshe Comparables

Compare Yaoyanshe with similar companies based on industry and business-model similarity.

Yaoyanshe comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Taimei Technology
83%
Shanhu Health Technology Co., Ltd.
79%
Bestudy (Shanghai) Medical Technology Co., Ltd.
77%

Yaoyanshe Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DAug 10, 2020
Series C ExtensionAug 10, 2020
Series CAug 16, 2019
Series BNov 19, 2018
Series AMay 1, 2018
Pre Seed
Nov 20, 2017

Yaoyanshe Investors

Notable investors and investment history

Yaoyanshe investors
InvestorRounds
Genesis CapitalSeries C, Series C Extension
Yuanjing CapitalPre Seed, Series C, Series C Extension, Series B, Series A, Series D
MPCSeries C, Series C Extension, Series B, Series D, Series A
Eastern Bell CapitalSeries D, Series C, Series C Extension
GGV CapitalSeries D
HongShan Capital Group (HSG)Series C, Series C Extension
Genesis CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2019

    $43M round led by Eastern Bell Capital and HongShan Capital Group.

  • May 1, 2018

    $16M round led by MPC

Yaoyanshe Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Yaoyanshe Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Yaoyanshe's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range46
Year Founded2012
Last FundingAug 10, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?